Class Certification In Investor Suit Against Generic Drugmaker Upheld On Appeal
PHILADELPHIA — A federal district court did not err in certifying a class of investors in a securities class action lawsuit against a generic drugmaker and two of its senior executives...To view the full article, register now.
Already a subscriber? Click here to view full article